BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
-8.71%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.37B
AUM Growth
+$1.37B
Cap. Flow
+$394M
Cap. Flow %
28.7%
Top 10 Hldgs %
60.15%
Holding
48
New
13
Increased
11
Reduced
1
Closed
–

Top Buys

1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
$102M
2
AMRN
Amarin Corp
AMRN
$53.1M
3
SWTX
SpringWorks Therapeutics
SWTX
$45M
4
SRPT icon
Sarepta Therapeutics
SRPT
$41.4M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
$30.3M

Top Sells

1
MRSN icon
Mersana Therapeutics
MRSN
$637K

Sector Composition

1 Healthcare 78.88%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ONCE
1
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$160M 11.6% 1,650,000 +1,050,000 +175% +$102M
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$134M 9.69% 1,715,560 – –
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$113M 8.21% 925,000 +25,000 +3% +$3.06M
IMMU
4
DELISTED
Immunomedics Inc
IMMU
$92.2M 6.68% 6,950,000 +383,000 +6% +$5.08M
ODT
5
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$87.5M 6.35% 3,363,377 – –
ALLK
6
DELISTED
Allakos
ALLK
$53.1M 3.85% 675,000 +200,000 +42% +$15.7M
AMRN
7
Amarin Corp
AMRN
$311M
$53.1M 3.85% +3,500,000 New +$53.1M
DBVT
8
DBV Technologies
DBVT
$264M
$45.6M 3.3% 5,300,000 – –
SWTX
9
DELISTED
SpringWorks Therapeutics
SWTX
$45M 3.26% +2,075,905 New +$45M
SRPT icon
10
Sarepta Therapeutics
SRPT
$1.78B
$41.4M 3% +550,000 New +$41.4M
SLDB icon
11
Solid Biosciences
SLDB
$427M
$40.3M 2.92% 3,896,872 +423,600 +12% +$4.38M
MDCO
12
DELISTED
Medicines Co
MDCO
$37.5M 2.72% 750,000 – –
ESPR icon
13
Esperion Therapeutics
ESPR
$448M
$35.7M 2.59% 975,000 – –
GOSS icon
14
Gossamer Bio
GOSS
$562M
$34.8M 2.53% 2,075,000 +200,000 +11% +$3.36M
QURE icon
15
uniQure
QURE
$896M
$34.1M 2.47% 865,400 +250,000 +41% +$9.84M
PTCT icon
16
PTC Therapeutics
PTCT
$3.92B
$33.8M 2.45% 1,000,000 – –
BMRN icon
17
BioMarin Pharmaceuticals
BMRN
$11.2B
$30.3M 2.2% +450,000 New +$30.3M
ARGX icon
18
argenx
ARGX
$43.6B
$22.8M 1.65% 200,000 – –
BCEL
19
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$21.2M 1.54% 1,733,583 – –
MIST icon
20
Milestone Pharmaceuticals
MIST
$156M
$20.6M 1.49% 1,102,194 – –
WVE icon
21
Wave Life Sciences
WVE
$1.53B
$20.5M 1.49% 1,000,000 – –
FOLD icon
22
Amicus Therapeutics
FOLD
$2.34B
$18.6M 1.35% 2,325,000 – –
RCKT icon
23
Rocket Pharmaceuticals
RCKT
$354M
$17.1M 1.24% 1,466,051 – –
APLS icon
24
Apellis Pharmaceuticals
APLS
$3.48B
$16.9M 1.22% +700,000 New +$16.9M
PRVL
25
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$13.8M 1% 1,123,105 – –
1
2